Today Sachiko presented her work on, "The Ubiquitin-Proteasome System as a Therapeutic Target in Medulloblastoma" to the multi-institutional Texas-Oklahoma Pediatric Neuro-Oncology Consortium. Her presentation was well received and considered promising as an approach for a clinical trial. The greatest value, of course, was in the multi-disciplinary exchange between clinicians, clinical researchers and basic scientists.
Congratulations again to Sachiko on an excellent presentation.
Unraveling rhabdomyosarcoma, osteosarcoma, dipg and medulloblastoma using engineering, biomedical, and translational research tools.
Friday, January 8, 2010
McAfee Foundation funds Preclinical Therapeutic Study for Alveolar Rhabdomyosarcoma
We are grateful to the Joanna McAfee Childhood Cancer Foundation for their 2nd grant in amount of $8,538 to evaluate a novel new compound for efficacy in a genetically-engineered mouse model of alveolar rhabdomyosarcoma. This study is done as part of the Pediatric Preclinical Testing Initiative at the our institution... an effort to speed discovery of clinically-feasible agents that can be moved to clinical trials for childhood cancer.
To learn more about JMCCF, and Joanna's & her family's story, click here.
To learn more about JMCCF, and Joanna's & her family's story, click here.
Subscribe to:
Posts (Atom)